Search research articles
Contact Us
Filters
Showing results (11-20 of 176) with videos related to
Page
of 18
Sort By:
Circulation
|
February 6, 2004
Evidence base for pacemaker mode selection: from physiology to randomized trials
Gervasio A Lamas, Kenneth A Ellenbogen
Heart (British Cardiac Society)
|
October 16, 2007
Where does the Occluded Artery Trial leave the late open artery hypothesis?
Gervasio A Lamas, Judith S Hochman
Journal of the American Heart Association
|
May 4, 2021
Lead and Cadmium as Cardiovascular Risk Factors: The Burden of Proof Has Been Met
Gervasio A Lamas, Francisco Ujueta, Ana Navas-Acien
Current Atherosclerosis Reports
|
November 9, 2016
Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy
Ehimen C Aneni, Esteban Escolar, Gervasio A Lamas
Journal of Cardiovascular Pharmacology and Therapeutics
|
January 12, 2010
Examining treatment of ST-elevation myocardial infarction: the importance of early intervention
Gervasio A Lamas, Esteban Escolar, David P Faxon
JAMA
|
August 7, 2013
Chelation therapy and cardiovascular outcomes--in reply
Gervasio A Lamas, Daniel Mark, Kerry L Lee
Trends in Cardiovascular Medicine
|
August 10, 2014
Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients
Julio G Peguero, Ivan Arenas, Gervasio A Lamas
Circulation. Arrhythmia and Electrophysiology
|
August 18, 2015
Response to Fang Fang, MB, PhD, John E. Sanderson, MD, Cheuk-man Yu, MD
Ivan A Arenas, Jason Jacobson, Gervasio A Lamas
Circulation. Arrhythmia and Electrophysiology
|
June 18, 2015
Routine use of biventricular pacing is not warranted for patients with heart block
Ivan A Arenas, Jason Jacobson, Gervasio A Lamas
American Heart Journal
|
June 25, 2004
Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials
Adam Splaver, Gervasio A Lamas, Charles H Hennekens
Page
of 18
Search research articles
Search
Showing results (11-20 of 176) with videos related to
Sort By:
Page
of 18
Circulation
|
February 6, 2004
Evidence base for pacemaker mode selection: from physiology to randomized trials
Gervasio A Lamas, Kenneth A Ellenbogen
Heart (British Cardiac Society)
|
October 16, 2007
Where does the Occluded Artery Trial leave the late open artery hypothesis?
Gervasio A Lamas, Judith S Hochman
Journal of the American Heart Association
|
May 4, 2021
Lead and Cadmium as Cardiovascular Risk Factors: The Burden of Proof Has Been Met
Gervasio A Lamas, Francisco Ujueta, Ana Navas-Acien
Current Atherosclerosis Reports
|
November 9, 2016
Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy
Ehimen C Aneni, Esteban Escolar, Gervasio A Lamas
Journal of Cardiovascular Pharmacology and Therapeutics
|
January 12, 2010
Examining treatment of ST-elevation myocardial infarction: the importance of early intervention
Gervasio A Lamas, Esteban Escolar, David P Faxon
JAMA
|
August 7, 2013
Chelation therapy and cardiovascular outcomes--in reply
Gervasio A Lamas, Daniel Mark, Kerry L Lee
Trends in Cardiovascular Medicine
|
August 10, 2014
Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients
Julio G Peguero, Ivan Arenas, Gervasio A Lamas
Circulation. Arrhythmia and Electrophysiology
|
August 18, 2015
Response to Fang Fang, MB, PhD, John E. Sanderson, MD, Cheuk-man Yu, MD
Ivan A Arenas, Jason Jacobson, Gervasio A Lamas
Circulation. Arrhythmia and Electrophysiology
|
June 18, 2015
Routine use of biventricular pacing is not warranted for patients with heart block
Ivan A Arenas, Jason Jacobson, Gervasio A Lamas
American Heart Journal
|
June 25, 2004
Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials
Adam Splaver, Gervasio A Lamas, Charles H Hennekens
Page
of 18